Hemogenyx Pharmaceuticals PLC (HEMO)

Currency in GBP
537.000
-179.000(-25.00%)
Closed·
HEMO Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Unusual trading volume
HEMO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
520.000728.000
52 wk Range
124.5001,199.960
Key Statistics
Bid/Ask
520.00 / 614.00
Prev. Close
716
Open
714
Day's Range
520-728
52 wk Range
124.5-1,199.96
Volume
315.38K
Average Volume (3m)
82.36K
1-Year Change
73.8%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HEMO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Hemogenyx Pharmaceuticals PLC Company Profile

Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer. The company’s lead product candidate is the HG-CT-1 therapy for the treatment of relapsed or refractory acute myeloid leukemia. It also develops chimeric bait receptor to treat viral infections derived and for certain cancer and neurological conditions; and CDX bi-specific antibody which eliminates hematopoietic stem cells/hematopoietic progenitors in a patient using bi-specific antibodies; and therapies for the improvement of bone marrow and blood stem cell transplant procedures. Hemogenyx Pharmaceuticals Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.

Compare HEMO to Peers and Sector

Metrics to compare
HEMO
Peers
Sector
Relationship
P/E Ratio
−6.4x−6.5x−0.6x
PEG Ratio
−0.23−0.060.00
Price/Book
40.2x4.8x2.6x
Price / LTM Sales
-21.4x3.3x
Upside (Analyst Target)
-94.3%39.1%
Fair Value Upside
Unlock−36.4%5.3%Unlock

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-0.79 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

HEMO Income Statement

People Also Watch

-
HE1H
0.00%
-
VRS
0.00%
-
VALX
0.00%
-
WSBN
+0.00%

FAQ

What Stock Exchange Does Hemogenyx Pharma Trade On?

Hemogenyx Pharma is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Hemogenyx Pharma?

The stock symbol for Hemogenyx Pharma is "HEMO."

What Is the Hemogenyx Pharma Market Cap?

As of today, Hemogenyx Pharma market cap is 28.20M.

What Is Hemogenyx Pharma's Earnings Per Share (TTM)?

The Hemogenyx Pharma EPS (TTM) is -1.70.

From a Technical Analysis Perspective, Is HEMO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Hemogenyx Pharma Stock Split?

Hemogenyx Pharma has split 1 times.

How Many Employees Does Hemogenyx Pharma Have?

Hemogenyx Pharma has 16 employees.

What is the current trading status of Hemogenyx Pharma (HEMO)?

As of 03 Sept 2025, Hemogenyx Pharma (HEMO) is trading at a price of 537.000, with a previous close of 716.00. The stock has fluctuated within a day range of 520.000 to 728.000, while its 52-week range spans from 124.500 to 1,199.960.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.